Lista de obras - Heiko van der Kuip - Dominio Público Uruguay

A Temperature of 40 °C Appears to be a Critical Threshold for Potentiating Cytotoxic Chemotherapy In Vitro and in Peritoneal Carcinomatosis Patients Undergoing HIPEC.

artículo científico publicado en 2015

A cell-based screen for resistance of Bcr-Abl-positive leukemia identifies the mutation pattern for PD166326, an alternative Abl kinase inhibitor

artículo científico publicado en 2004

Apoptosis of mesothelial cells caused by unphysiological characteristics of peritoneal dialysis fluids

artículo científico publicado en 2003

Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices

artículo científico publicado en 2015

Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1).

artículo científico publicado en 2013

Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct-4.

artículo científico publicado en 2013

Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy

artículo científico publicado en 2007

DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma

artículo científico publicado en 2011

Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts

artículo científico publicado en 2010

Estrogen-mediated downregulation of CD24 in breast cancer cells

artículo científico publicado en 2008

Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast

artículo científico publicado en 2008

Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach

artículo científico publicado en 2012

Imatinib mesylate (STI571) prevents the mutator phenotype of Bcr-Abl in hematopoietic cell lines

artículo científico publicado en 2004

Imatinib mesylate induces cisplatin hypersensitivity in Bcr-Abl+ cells by differential modulation of p53 transcriptional and proapoptotic activity

artículo científico publicado en 2009

Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571).

artículo científico publicado en 2003

Mechanisms of clinical resistance to small molecule tyrosine kinase inhibitors targeting oncogenic tyrosine kinases

artículo científico publicado en 2005

Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes

artículo científico publicado en 2016

Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases

artículo científico publicado en 2016

Oncogenic stress induced by acute hyper-activation of Bcr-Abl leads to cell death upon induction of excessive aerobic glycolysis

artículo científico publicado en 2011

Protocols and characterization data for 2D, 3D, and slice-based tumor models from the PREDECT project

artículo científico publicado en 2017

Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors

artículo científico publicado en 2012

Shed human enterocytes as a tool for the study of expression and function of intestinal drug-metabolizing enzymes and transporters

artículo científico publicado en 2002

Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment

artículo científico publicado en 2006

Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinib

artículo científico publicado en 2005

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).

artículo científico publicado en 2008

Three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro/ex vivo

artículo científico

c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study

artículo científico publicado en 2005

p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin

artículo científico publicado en 2011

Lista de obras de Heiko van der Kuip

A Temperature of 40 °C Appears to be a Critical Threshold for Potentiating Cytotoxic Chemotherapy In Vitro and in Peritoneal Carcinomatosis Patients Undergoing HIPEC.

A cell-based screen for resistance of Bcr-Abl-positive leukemia identifies the mutation pattern for PD166326, an alternative Abl kinase inhibitor

Apoptosis of mesothelial cells caused by unphysiological characteristics of peritoneal dialysis fluids

Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices

Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1).

Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct-4.

Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy

DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma

Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts

Estrogen-mediated downregulation of CD24 in breast cancer cells

Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast

Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach

Imatinib mesylate (STI571) prevents the mutator phenotype of Bcr-Abl in hematopoietic cell lines

Imatinib mesylate induces cisplatin hypersensitivity in Bcr-Abl+ cells by differential modulation of p53 transcriptional and proapoptotic activity

Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571).

Mechanisms of clinical resistance to small molecule tyrosine kinase inhibitors targeting oncogenic tyrosine kinases

Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes

Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases

Oncogenic stress induced by acute hyper-activation of Bcr-Abl leads to cell death upon induction of excessive aerobic glycolysis

Protocols and characterization data for 2D, 3D, and slice-based tumor models from the PREDECT project

Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors

Shed human enterocytes as a tool for the study of expression and function of intestinal drug-metabolizing enzymes and transporters

Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment

Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinib

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).

Three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro/ex vivo

c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study

p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin